-
Product Insights
NewLikelihood of Approval Analysis for Pleural Disease
Overview How likely is it that the drugs in Pleural Disease will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Pleural Disease Overview Pleural disorders encompass a spectrum of conditions affecting the...
-
Product Insights
Leishmaniasis (Kala-Azar) – Drugs In Development, 2023
Global Markets Direct’s, ‘Leishmaniasis (Kala-Azar) - Drugs In Development, 2023’, provides an overview of the Leishmaniasis (Kala-Azar) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Leishmaniasis (Kala-Azar), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Trypanosomiasis – Drugs In Development, 2023
Global Markets Direct’s, ‘Trypanosomiasis - Drugs In Development, 2023’, provides an overview of the Trypanosomiasis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Trypanosomiasis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Product Insights
Cryptococcal Meningitis – Drugs In Development, 2023
Global Markets Direct’s, ‘Cryptococcal Meningitis - Drugs In Development, 2023’, provides an overview of the Cryptococcal Meningitis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Cryptococcal Meningitis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Fungal Meningitis – Drugs In Development, 2023
Global Markets Direct’s, ‘Fungal Meningitis - Drugs In Development, 2023’, provides an overview of the Fungal Meningitis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Fungal Meningitis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
African Trypanosomiasis – Drugs In Development, 2023
Global Markets Direct’s, ‘African Trypanosomiasis - Drugs In Development, 2023’, provides an overview of the African Trypanosomiasis pipeline landscape. The report provides comprehensive information on the therapeutics under development for African Trypanosomiasis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Onchocerciasis (River Blindness) – Drugs In Development, 2023
Global Markets Direct’s, ‘Onchocerciasis (River Blindness) - Drugs In Development, 2023’, provides an overview of the Onchocerciasis (River Blindness) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Onchocerciasis (River Blindness), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Product Insights
Nematodal (Round Worm) Infections – Drugs In Development, 2023
Global Markets Direct’s, ‘Nematodal (Round Worm) Infections - Drugs In Development, 2023’, provides an overview of the Nematodal (Round Worm) Infections pipeline landscape. The report provides comprehensive information on the therapeutics under development for Nematodal (Round Worm) Infections, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press...
-
Product Insights
Meningitis – Drugs In Development, 2023
Global Markets Direct’s, ‘Meningitis - Drugs In Development, 2023’, provides an overview of the Meningitis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Meningitis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Product Insights
Chagas Disease (American Trypanosomiasis) – Drugs In Development, 2023
Global Markets Direct’s, ‘Chagas Disease (American Trypanosomiasis) - Drugs In Development, 2023’, provides an overview of the Chagas Disease (American Trypanosomiasis) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Chagas Disease (American Trypanosomiasis), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press...